FDA
approval
· 2023-07-12
FDA Approved: LACOSAMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' supplemental application for lacosamide, a generic antiseizure medication used as adjunctive therapy for partial-onset seiz…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LACOSAMIDE (LACOSAMIDE)